About Ellenbarrie Industrial Gases Limited
Ellenbarrie Industrial Gases Limited, incorporated in 1973, is one of India’s leading manufacturers and suppliers of industrial, medical, and speciality gases. Headquartered in Kolkata, the company has a diverse portfolio that includes oxygen, nitrogen, helium, hydrogen, argon, acetylene, carbon dioxide, LPG, dry ice, and medical oxygen, catering to over 1,800 customers across various industries.
With eight manufacturing facilities across India and a strong presence in sectors like steel, pharmaceuticals, healthcare, petrochemicals, defence, and infrastructure, Ellenbarrie also offers engineering services such as installation of tonnage air separation units (ASUs), medical gas pipeline systems, and healthcare equipment.
Some of its key clients include AIIMS, Dr. Reddy’s Laboratories, Laurus Labs, GMM Pfaudler, and public sector oil marketing companies. As of FY25, the company has shown robust growth in revenue and profitability, with revenue rising to ?348.43 Cr and profit after tax increasing by 84% YoY to ?83.29 Cr.
Why To Invest in Ellenbarrie Industrial Gases Limited
Strong Financial Growth: Ellenbarrie’s PAT grew 84% in FY25, and EBITDA margin expanded to an impressive 35.12%. ROE stands at 16.88%, showing strong shareholder returns.
Diverse Industrial Base: Serving over 1,800 clients across critical sectors ensures revenue stability and reduces dependency on any single segment.
Capex-Driven Expansion: IPO proceeds will be used to reduce debt and set up a new Air Separation Unit with 220 TPD capacity, boosting future earnings potential.
Operational Excellence: The company operates in a largely monopolistic niche, with strong client retention, in-house engineering capabilities, and strategically located facilities.
Favorable Industry Tailwinds: Rising demand for industrial and medical gases in healthcare, steel, and pharma sectors positions the company for long-term growth.
Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
---|---|---|---|
Assets | 845.97 | 672.54 | 551.27 |
Revenue | 348.43 | 290.20 | 223.71 |
Profit After Tax | 83.29 | 45.29 | 28.14 |
EBITDA | 109.74 | 61.53 | 33.59 |
Net Worth | 333.62 | 250.15 | 203.32 |
Reserves and Surplus | 467.17 | 403.35 | 356.51 |
Total Borrowing | 245.30 | 176.90 | 101.10 |
Explore Other Products